These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30584432)

  • 21. Effects of food items and related nutrients on metabolic syndrome using Bayesian multilevel modelling using the Tehran Lipid and Glucose Study (TLGS): a cohort study.
    Cheraghi Z; Nedjat S; Mirmiran P; Moslehi N; Mansournia N; Etminan M; Mansournia MA; McCandless LC
    BMJ Open; 2018 Dec; 8(12):e020642. PubMed ID: 30567817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-Related Quality of Life in Tehran Lipid and Glucose Study.
    Amiri P; Jalali-Farahani S; Vahedi-Notash G; Cheraghi L; Azizi F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84745. PubMed ID: 30584433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial aggregation and linkage analysis with covariates for metabolic syndrome risk factors.
    Naseri P; Khodakarim S; Guity K; Daneshpour MS
    Gene; 2018 Jun; 659():118-122. PubMed ID: 29548861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II.
    Azizi F; Ghanbarian A; Momenan AA; Hadaegh F; Mirmiran P; Hedayati M; Mehrabi Y; Zahedi-Asl S;
    Trials; 2009 Jan; 10():5. PubMed ID: 19166627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is There any Association between Age at Menarche and Risk of Metabolic Syndrome? The Tehran Lipid & Glucose Study.
    Farahmand M; Ramezani Tehrani F; Behboudi Gandevani S; Azizi F
    Arch Iran Med; 2019 Sep; 22(9):495-500. PubMed ID: 31679370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran Lipid and Glucose Study.
    Daneshpour MS; Faam B; Mansournia MA; Hedayati M; Halalkhor S; Mesbah-Namin SA; Shojaei S; Zarkesh M; Azizi F
    Endocrine; 2012 Feb; 41(1):103-10. PubMed ID: 22105741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dynamics of metabolic syndrome development from its isolated components among iranian children and adolescents: Findings from 17 Years of the Tehran Lipid and Glucose Study (TLGS).
    Bagheri P; Khalil D; Seif M; Khedmati Morasae E; Bahramali E; Azizi F; Rezaianzadeh A
    Diabetes Metab Syndr; 2021; 15(1):99-108. PubMed ID: 33321311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Parizadeh D; Momenan AA; Amouzegar A; Azizi F; Hadaegh F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84738. PubMed ID: 30584430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceived social support and health-related quality of life (HRQoL) in Tehranian adults: Tehran lipid and glucose study.
    Jalali-Farahani S; Amiri P; Karimi M; Vahedi-Notash G; Amirshekari G; Azizi F
    Health Qual Life Outcomes; 2018 May; 16(1):90. PubMed ID: 29747652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
    Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
    Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying new associated pleiotropic SNPs with lipids by simultaneous test of multiple longitudinal traits: An Iranian family-based study.
    Hosseinzadeh N; Mehrabi Y; Daneshpour MS; Zayeri F; Guity K; Azizi F
    Gene; 2019 Apr; 692():156-169. PubMed ID: 30658068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
    Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overweight and Obesity: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Barzin M; Valizadeh M; Serahati S; Mahdavi M; Azizi F; Hosseinpanah F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84778. PubMed ID: 30584443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic correlation and causal relationships between cardio-metabolic traits and lung function impairment.
    Wielscher M; Amaral AFS; van der Plaat D; Wain LV; Sebert S; Mosen-Ansorena D; Auvinen J; Herzig KH; Dehghan A; Jarvis DL; Jarvelin MR
    Genome Med; 2021 Jun; 13(1):104. PubMed ID: 34154662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Main facilitators of smoking among young males in tehran: tehran lipid and glucose study.
    Rostami Dovom M; Ramezani Tehrani F; Amiri P; Amirshekari G; Farahmand M; Azizi F
    Iran Red Crescent Med J; 2014 Sep; 16(9):e15429. PubMed ID: 25593726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional knowledge, attitude and practice of Tehranian adults and their relation to serum lipid and lipoproteins: Tehran lipid and glucose study.
    Mirmiran P; Mohammadi-Nasrabadi F; Omidvar N; Hosseini-Esfahani F; Hamayeli-Mehrabani H; Mehrabi Y; Azizi F
    Ann Nutr Metab; 2010; 56(3):233-40. PubMed ID: 20375546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study.
    Ramezankhani A; Harati H; Bozorgmanesh M; Tohidi M; Khalili D; Azizi F; Hadaegh F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84784. PubMed ID: 30584445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 10-year trend of adult diabetes, prediabetes and associated risk factors in Tehran: Phases 1 and 4 of Tehran Lipid and Glucose Study.
    Mahtab N; Farzad H; Mohsen B; Nakisa D
    Diabetes Metab Syndr; 2017; 11(3):183-187. PubMed ID: 27666004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is systolic blood pressure sufficient for classification of blood pressure and determination of hypertension based on JNC-VI in an Iranian adult population? Tehran lipid and glucose study (TLGS).
    Azizi F; Rashidi A; Ghanbarian A; Madjid M
    J Hum Hypertens; 2003 Apr; 17(4):287-91. PubMed ID: 12692573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Risk of CHD in the Presence of rs7865618 (A allele): Tehran Lipid and Glucose Study.
    Matoo S; Fallah MS; Daneshpour MS; Mousavi R; Sedaghati Khayat B; Hasanzad M; Azizi F
    Arch Iran Med; 2017 Mar; 20(3):153-157. PubMed ID: 28287809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.